BDBM380103 1-methyl-N-[4-(4-oxo- 3,4-dihydrophthalazin-1- yl)phenyl]-1H-indazole- 3-carboxamide::US9926282, Example 98

SMILES O=C(Nc1ccc(cc1)-c1n[nH]c(=O)c2ccccc12)c1n[nH]c2ccccc12

InChI Key InChIKey=OBBCYBCNDIVGFK-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 380103   

TargetRho-associated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM380103(1-methyl-N-[4-(4-oxo- 3,4-dihydrophthalazin-1- yl)...)
Affinity DataIC50: 100nMAssay Description:The effectiveness of compounds of the present invention as ROCK inhibitors can be determined in a 30 μL assay containing 20 mM HEPES, pH 7.5, 20...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2020
Entry Details
US Patent

TargetRho-associated protein kinase 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM380103(1-methyl-N-[4-(4-oxo- 3,4-dihydrophthalazin-1- yl)...)
Affinity DataIC50: 100nMAssay Description:The effectiveness of compounds of the present invention as ROCK inhibitors can be determined in a 30 μL assay containing 20 mM HEPES, pH 7.5, 20...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2020
Entry Details
US Patent